---
title: "Prasinezumab Parkinson's Clinical Trials | Parkinson's Pathways"
description: "Recruiting clinical trials studying prasinezumab, an alpha-synuclein antibody, for Parkinson's disease. See enrolling studies and get notified of new trials."
canonical_url: "https://parkinsonspathways.com/trials/drug/prasinezumab"
topic_type: drug
source: "Parkinson's Pathways"
---
# Prasinezumab Clinical Trials for Parkinson's

Prasinezumab is an investigational antibody designed to target alpha-synuclein, the protein that clumps together in the brains of people with Parkinson's. The hope is that clearing or neutralizing this protein could slow how quickly the disease progresses.

It belongs to a wave of disease-modifying drugs aimed at the underlying biology of Parkinson's rather than just its symptoms. Trials have studied it mainly in people in the earlier stages of the disease.

Below are the recruiting trials we track that involve prasinezumab. Sign up to be emailed when a new trial opens.

## 1 recruiting trial

- [A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants With Early-Stage Parkinson's Disease](https://parkinsonspathways.com/trial/NCT07174310) — New medication slows early progression

## Related topics

- [Ambroxol](https://parkinsonspathways.com/trials/drug/ambroxol)
- [Bemdaneprocel](https://parkinsonspathways.com/trials/drug/bemdaneprocel)

## Related

- [Browse all recruiting trials](https://parkinsonspathways.com/trials)
- [Match yourself to relevant trials](https://parkinsonspathways.com/match)
- [Get the free Monday digest of new recruiting Parkinson's trials](https://parkinsonspathways.com/digest)